NCT05529407

Brief Summary

The aim of this study is to compare the success rates of vaginismus therapy using a tampon or a dilator during exposure

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

September 2, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 7, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2023

Completed
Last Updated

September 7, 2022

Status Verified

May 1, 2022

Enrollment Period

3.2 years

First QC Date

September 2, 2022

Last Update Submit

September 2, 2022

Conditions

Keywords

genitopelvic pain disorder, vaginismus

Outcome Measures

Primary Outcomes (1)

  • Sucessfull Intercourse-Diary

    3 point scale: 1-did not try. 2- try but unseccesfull. 3- successfull intercourse

    30 days

Secondary Outcomes (3)

  • GRISS: Golombuk Rust Inventory of Sexual Satisfaction

    30 day

  • FSFI Score

    30 day

  • Fear of Coitus Subscale

    30 day

Study Arms (2)

Simple Vaginal Tampon

EXPERIMENTAL

Dilation exercises will be performed with tampon

Device: Simple Vaginal Tampon

Glass Vaginal Dilator

EXPERIMENTAL

Dilation exercises will be performed with vaginal dilator

Device: Glass Vaginal Trainer

Interventions

Use of single use vaginal tampons

Also known as: SVT
Simple Vaginal Tampon

Use of glass vaginal trainers

Also known as: GVT
Glass Vaginal Dilator

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • non-pregnant/non lactating women aged between 18-50
  • diagnosed with primary vaginismus of Lamont level II or higher

You may not qualify if:

  • hymenal abnormalities, congenital vaginal abnormalities, vulvodynia, secondary vaginismus following physical or psychological trauma, infection, menopausal period or pelvic pathology and with any psychiatric or physiological disease.
  • Patients with husbands possessing a history of sexual dysfunction (erectile dysfunction or premature ejaculation, for example)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bezmialem Vakif University

Istanbul, 34093, Turkey (Türkiye)

RECRUITING

Bezmialem Vakif University

Istanbul, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Aslan M, Yavuzkir S, Baykara S. Is "Dilator Use" More Effective Than "Finger Use" in Exposure Therapy in Vaginismus Treatment? J Sex Marital Ther. 2020;46(4):354-360. doi: 10.1080/0092623X.2020.1716907. Epub 2020 Feb 13.

    PMID: 32052704BACKGROUND

MeSH Terms

Conditions

Vaginismus

Condition Hierarchy (Ancestors)

Vaginal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesSexual Dysfunction, PhysiologicalSexual Dysfunctions, PsychologicalMental Disorders

Central Study Contacts

Ayse Filiz Gokmen Karasu

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

September 2, 2022

First Posted

September 7, 2022

Study Start

June 1, 2020

Primary Completion

August 1, 2023

Study Completion

August 30, 2023

Last Updated

September 7, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations